ANTICANCER AGENTS.
D000477:Alkylating Agents; D000630:Aminopterin; D000970:Antineoplastic Agents; D010478:Chemotherapy, Cancer, Regional Perfusion; D016039:Corneal Transplantation; D004358:Drug Therapy; D005134:Eye Neoplasms; D005260:Female; D005472:Fluorouracil; D006801:Humans; D008431:Maternal-Fetal Exchange; D009369:Neoplasms / Q000628:therapy*; D009588:Nitrogen Mustard Compounds; D009885:Ophthalmology; D011247:Pregnancy; D011739:Pyrimethamine; D014116:Toxicology; D014123:Toxoplasmosis; D014126:Toxoplasmosis, Ocular; D014181:Transplantation Immunology; D014605:Uveitis
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D000630:Aminopterin; D005472:Fluorouracil; D011739:Pyrimethamine
ALKYLATING AGENTS; AMINOPTERIN; ANTINEOPLASTIC AGENTS; CORNEAL TRANSPLANTATION; DRUG THERAPY; EYE NEOPLASMS; FLUOROURACIL; ISOLATION PERFUSION; MATERNAL-FETAL EXCHANGE; NEOPLASM THERAPY; NITROGEN MUSTARD COMPOUNDS; OPHTHALMOLOGY; PREGNANCY; PYRIMETHAMINE; TOXICOLOGIC REPORT; TOXOPLASMOSIS, OCULAR; TRANSPLANTATION IMMUNOLOGY; UVEITIS